Loading clinical trials...
Loading clinical trials...
This is a retrospective biobank study evaluating the impact of novel genetic variants in a population of 6-mercaptopurine treated pediatric acute lymphoblastic leukemia patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cipherome, Inc.
Collaborators
NCT06074666 · Acute Lymphoblastic Leukemia, Pediatric
NCT05512169 · ALL, Childhood, Pediatric Cancer, and more
NCT07216846 · Fall, Fall Accident, and more
NCT07108868 · Lymphoma, CLL, and more
NCT06421155 · Acute Leukemia, Acute Lymphoblastic Leukemia, Pediatric, and more
Stanford University
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions